DK0474712T3 - Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat - Google Patents

Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat

Info

Publication number
DK0474712T3
DK0474712T3 DK90908504.5T DK90908504T DK0474712T3 DK 0474712 T3 DK0474712 T3 DK 0474712T3 DK 90908504 T DK90908504 T DK 90908504T DK 0474712 T3 DK0474712 T3 DK 0474712T3
Authority
DK
Denmark
Prior art keywords
pct
pharmaceutical composition
preparation
carbon atoms
alkyl
Prior art date
Application number
DK90908504.5T
Other languages
English (en)
Inventor
Manuel Modolell
Gerhard Munder
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of DK0474712T3 publication Critical patent/DK0474712T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
DK90908504.5T 1989-06-02 1990-05-31 Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat DK0474712T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3918082A DE3918082A1 (de) 1989-06-02 1989-06-02 Mittel gegen autoimmunerkrankungen

Publications (1)

Publication Number Publication Date
DK0474712T3 true DK0474712T3 (da) 1993-11-29

Family

ID=6381972

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90908504.5T DK0474712T3 (da) 1989-06-02 1990-05-31 Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat

Country Status (14)

Country Link
US (1) US5266564A (da)
EP (1) EP0474712B1 (da)
JP (1) JP2977894B2 (da)
AT (1) ATE94757T1 (da)
AU (1) AU5670690A (da)
CA (1) CA2056421C (da)
CS (1) CS276439B6 (da)
DE (2) DE3918082A1 (da)
DK (1) DK0474712T3 (da)
ES (1) ES2060173T3 (da)
GR (1) GR1001195B (da)
IE (1) IE64039B1 (da)
WO (1) WO1990014829A1 (da)
ZA (1) ZA904196B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3941009A1 (de) * 1989-12-12 1991-06-13 Medmark Pharma Gmbh Eliminierung von aktivierten lymphozyten
HU228630B1 (en) * 1996-02-09 2013-04-29 Abbott Biotech Ltd Use of human anti bodies that bind human tnf-alpha and process for inhibiting of human tnf-alpha activity
JP2002532553A (ja) 1998-12-21 2002-10-02 インケイサ．ソシエダ アノニマ 有害な胃腸副作用を引き起こさない有力な抗炎症剤としてのエーテルリゾリン脂質の使用
SE9902155L (sv) * 1999-06-09 2000-12-10 Bjoern Rydevik Serum antibodies
JP2002228764A (ja) * 2001-02-02 2002-08-14 Fuji Photo Film Co Ltd 透光性シート体検出装置
ES2393762T3 (es) 2006-11-10 2012-12-27 Alphaptose Gmbh Procedimientos y composiciones para detectar miméticos de ligandos de receptores
CN103816127A (zh) * 2006-11-10 2014-05-28 阿尔法普托斯有限公司 含有三取代甘油化合物的口服剂型
US20100130449A1 (en) * 2006-11-10 2010-05-27 Alphaptose Gmbh Use of Tri-Substituted Glycerol Compounds for the Treatment of Radiation Injuries
EP2120873B1 (en) * 2006-12-20 2012-06-27 Alphaptose Gmbh Topical dosage form comprising tri-substituted glycerol compounds
US8697138B2 (en) 2007-03-28 2014-04-15 Aker Biomarine As Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
CA2682068C (en) 2007-03-28 2017-11-28 Aker Biomarine Asa Bioeffective krill oil compositions
KR101192880B1 (ko) * 2007-08-29 2012-10-18 에이커 바이오마린 에이에스에이 새로운 크릴 밀 제조 방법
US20100226977A1 (en) * 2007-08-29 2010-09-09 Aker Biomarine Asa Low viscosity phospholipid compositions
US8372812B2 (en) * 2009-02-26 2013-02-12 Aker Biomarine Asa Phospholipid and protein tablets
WO2013156630A1 (en) 2012-04-20 2013-10-24 Alphaptose Gmbh S-enantiomer of a tri-substituted glycerol compound
AU2014203179C1 (en) 2013-06-14 2017-05-04 Aker Biomarine Antarctic As Lipid extraction processes
GB201400431D0 (en) 2014-01-10 2014-02-26 Aker Biomarine As Phospholipid compositions and their preparation
BR112017017310B1 (pt) 2015-02-11 2022-07-26 Aker Biomarine Antarctic As Composições lipídicas e suplemento alimentar ou nutricional, alimento médico ou funcional e veículo de liberação oral compreendendo as ditas composições
EP3256003B1 (en) 2015-02-11 2022-11-09 Aker Biomarine Antarctic AS Lipid extraction processes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009342C3 (de) * 1970-02-27 1980-12-18 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Glycerin-alkyläther-(l)-phosphorsäure-(3)-monocholinestern
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
DE2619686C2 (de) * 1976-05-04 1986-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung eines Lysolecithins zur Tumorbehandlung
CH670763A5 (da) * 1985-08-02 1989-07-14 Seuref Ag
DE3530767A1 (de) * 1985-08-28 1987-03-12 Max Planck Gesellschaft Mittel gegen multiple sklerose

Also Published As

Publication number Publication date
DE3918082A1 (de) 1991-01-24
CS276439B6 (en) 1992-05-13
CA2056421A1 (en) 1990-12-03
EP0474712A1 (de) 1992-03-18
EP0474712B1 (de) 1993-09-22
CA2056421C (en) 2000-10-10
DE59002863D1 (de) 1993-10-28
CS268990A3 (en) 1992-01-15
DE3918082C2 (da) 1992-02-06
US5266564A (en) 1993-11-30
ATE94757T1 (de) 1993-10-15
JPH04507096A (ja) 1992-12-10
JP2977894B2 (ja) 1999-11-15
ZA904196B (en) 1991-03-27
IE64039B1 (en) 1995-06-28
ES2060173T3 (es) 1994-11-16
GR1001195B (el) 1993-06-07
WO1990014829A1 (de) 1990-12-13
GR900100406A (en) 1991-11-15
IE901987L (en) 1990-12-02
AU5670690A (en) 1991-01-07

Similar Documents

Publication Publication Date Title
DK0474712T3 (da) Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat
DK160877C (da) Fremgangsmaade til fremstilling af 2-penemforbindelser
HUT51863A (da)
SE9002206D0 (sv) New compounds
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
FI894061A0 (fi) Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita
EP0481299A3 (en) N-phenyl-piperidyl-4-amines and drugs containing them
ES8200680A1 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
AU601177B2 (en) Thiodiazolylurea-containing agent for defoliating plants
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
GB2243605A (en) Fluorinated 4"-cyano substituted terphenyls
FI873800A (fi) Nor-kolansyraderivat, foerfarande foer deras framstaellning, deras anvaendning samt farmaceutiska kompositioner innehaollande desamma.
ATE69611T1 (de) Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
AU527523B2 (en) Hexahydro-1,4-oxazepines
SE8303721D0 (sv) Neue eburnan-oxim-ether-derivative und verfahren zur herstellung dieser verbindungen
DE69017146T2 (de) Verfahren zur Herstellung von 2-(3-Pyridyl)-Tetrahydrothiopyran-2-carbonsäurethioamid-1-(1R,2R)oxyden, die so erhaltenen 2-(3-Pyridyl)-Tetrahydrothiopyran-2-carbothioamid-1-(1R,2R)oxyde und diese enthaltende pharmazeutische Zusammenstellungen.
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
ATE19472T1 (de) Verwendung von 5-phenyl-1,4-benzodoazepinen zur herstellung von analgetisch wirksamen pharmazeutischen zubereitungen.
ATE36536T1 (de) Phosphoroimidate.